| 1 |
Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum.  |
미소장 |
| 2 |
Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K,- Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 1973; 20: 415-455. |
미소장 |
| 3 |
Functional imaging in relation to parkinsonian syndromes.  |
미소장 |
| 4 |
Neumeyer JL, Wang S, Gao Y, Milius RA, Kula NS, Campbell A, Baldessarini RJ, Zea-Ponce Y, Baldwin Innis RB. RM,N- α Fluoroalkyl analogs of (1R)-2β- carbomethoxy-3β- (4-iodophenyl)- tropane (β- CIT): Radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporter. J Med Chem 1994; 37: 1558-1561. |
미소장 |
| 5 |
SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.  |
미소장 |
| 6 |
[18F]CFT ([18F]WIN 35,428), a radioligand to study the dopamine transporter with PET: Biodistribution in rats  |
미소장 |
| 7 |
Huang WS, Lee MS, Lin JC, Chen CY, Yang YW, Lin SZ, Wey SP. Usefulness of brain 99mTc-TRODAT-1 SPET for the evaluation of Parkinson's disease. Eur J Nucl Med Mol Imaging 2004; 31: 155-161. |
미소장 |
| 8 |
Kim HJ, Im JH, Yang SO, Moon DH, Ryu JS, Bong JK, Nam KP, Cheon JH, Lee MC, Lee hK. Imaging and quantitation of dopamine transporters with iodine-123- IPT in normal and Parkinson's disease subjects. J Nucl Med 1997; 38: 1703- 1711. |
미소장 |
| 9 |
[18F] beta-CIT-FP is superior to [11C] beta-CIT-FP for quantitation of the dopamine transporter.  |
미소장 |
| 10 |
One-step high-radiochemical-yield synthesis of [ 18F]FP-CIT using a protic solvent system  |
미소장 |
| 11 |
Dopamine transporter imaging with fluorine-18-FPCIT and PET.  |
미소장 |
| 12 |
Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: A PET study  |
미소장 |
| 13 |
[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.  |
미소장 |
| 14 |
Usefulness of a dopamine transporter PET ligand [(18)F]beta-CFT in assessing disability in Parkinson's disease.  |
미소장 |
| 15 |
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY  |
미소장 |
| 16 |
Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.  |
미소장 |
| 17 |
Effects of age on dopamine transporters in healthy humans.  |
미소장 |
| 18 |
Effect of age and gender on dopamine transporter imaging with [^1^2^3I]FP-CIT SPET in healthy volunteers  |
미소장 |
| 19 |
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study  |
미소장 |
| 20 |
Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.  |
미소장 |
| 21 |
Levodopa and the progression of Parkinson's disease.  |
미소장 |
| 22 |
Essential tremor course and disability: a clinicopathologic study of 20 cases.  |
미소장 |
| 23 |
Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study.  |
미소장 |
| 24 |
Accuracy of diagnosis in patients with presumed Parkinson's disease.  |
미소장 |
| 25 |
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.  |
미소장 |
| 26 |
Long duration asymmetrical postural tremor is likely to predict development of Parkinson's disease and not essential tremor: clinical follow up study of 13 cases.  |
미소장 |
| 27 |
Varrone A, Marek KL, Jennings D, Innis RB, Seibyl JP. [1231I]- CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson s disease and multiple system atrophy. Mov Disord 2001; 16: 1023- 1032. |
미소장 |
| 28 |
Antonini A, Benti R, De Notaris R, Tesei S, Zecchinelli A, Sacilotto G, Meucci N, Canesi M, Mariani C, Pezzoli G, Gerundini P. 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson s disease, multiple system atrophy, and progressive supranuclear palsy. Neurol Sci 2003; 24: 149-150. |
미소장 |
| 29 |
Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients  |
미소장 |
| 30 |
Voxel-wise analysis of [123I]β-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease  |
미소장 |
| 31 |
Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis.  |
미소장 |
| 32 |
ARTERIOSCLEROTIC PARKINSONISM  |
미소장 |
| 33 |
Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis  |
미소장 |
| 34 |
[123I]β‐CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease  |
미소장 |
| 35 |
123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.  |
미소장 |
| 36 |
Asymmetry of neuroleptic-induced rigidity: Development of quantitative methods and clinical correlates  |
미소장 |
| 37 |
Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT.  |
미소장 |
| 38 |
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.  |
미소장 |
| 39 |
Merdes AR, Hansen LA, Jeste DV, Galasko D, Hofstetter CR, Ho GJ, Thal LJ, Corey-Bloom J. Influenceof Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology 2003; 60: 1586 - 1590. |
미소장 |
| 40 |
Eerola J, Tienari PJ, Kaakkola S, Nikkinen P, Launes J. How useful is [123I]-CIT SPECT in clinical practice? J Neurol Neurosurg Psychiatry 2005; 76: 1211-1216. |
미소장 |
| 41 |
Dementia with Lewy bodies versus Alzheimer's disease: Role of dopamine transporter imaging  |
미소장 |
| 42 |
Idiopathic hyposmia as a preclinical sign of Parkinson's disease  |
미소장 |
| 43 |
Detection of presymptomatic Parkinson's disease: Combining smell tests, transcranial sonography, and SPECT  |
미소장 |
| 44 |
Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD.  |
미소장 |
| 45 |
Alzheimer's disease: genes, proteins, and therapy.  |
미소장 |
| 46 |
NEUROPATHOLOGY OF ALZHEIMER'S DISEASE AND RELATED DISORDERS  |
미소장 |
| 47 |
The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes.  |
미소장 |
| 48 |
Amyloid beta protein (1-40) forms calcium-permeable, Zn2+-sensitive channel in reconstituted lipid vesicles.  |
미소장 |
| 49 |
Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins.  |
미소장 |
| 50 |
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids  |
미소장 |
| 51 |
The morphological phenotype of β-amyloid plaques and associated neuritic changes in Alzheimer’s disease  |
미소장 |
| 52 |
Neuropathology of cognitively normal elderly.  |
미소장 |
| 53 |
Physiological roles for amyloid beta peptides.  |
미소장 |
| 54 |
Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.  |
미소장 |
| 55 |
F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain.  |
미소장 |
| 56 |
Peripheral metabolism of [ 18F]FDDNP and cerebral uptake of its labelled metabolites  |
미소장 |
| 57 |
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B  |
미소장 |
| 58 |
Price JC, Klunk WE, Lopresti BJ, Lu X, Hoge JA, Ziolko SK, Holt DP, Meltzer CC, Dekosky ST, Mathis CA. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab 2005; 25: 1528-1547. |
미소장 |
| 59 |
In-Vivo Imaging of Alzheimer Disease beta-Amyloid With [^1^1C]SB-13 PET  |
미소장 |
| 60 |
PET of brain amyloid and tau in mild cognitive impairment.  |
미소장 |
| 61 |
11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration.  |
미소장 |
| 62 |
PET imaging of amyloid deposition in patients with mild cognitive impairment  |
미소장 |
| 63 |
Frequent amyloid deposition without significant cognitive impairment among the elderly.  |
미소장 |
| 64 |
[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease.  |
미소장 |
| 65 |
Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease  |
미소장 |
| 66 |
Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.  |
미소장 |
| 67 |
Current progress in beta-amyloid immunotherapy  |
미소장 |
| 68 |
Blokland A. Acetylcholine: A Neurotransmitter for Learning and Memory? Brain Res Rev 1996; 21: 285-300. |
미소장 |
| 69 |
Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch1–Ch6)  |
미소장 |
| 70 |
Cholinergic innervation in the human hippocampal formation including the entorhinal cortex.  |
미소장 |
| 71 |
Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology  |
미소장 |
| 72 |
Synthesis and in vitro evaluation of new benzovesamicol analogues as potential imaging probes for the vesicular acetylcholine transporter.  |
미소장 |
| 73 |
Improved synthesis and radiolabeling of [11C]MP4A, a suitable ligand for the investigation of the cholinergic system using PET.  |
미소장 |
| 74 |
Synthesis of 1-[ 11c]methylpiperidin-4-yl propionate ([ 11c]pmp) for in vivo measurements of acetylcholinesterase activity  |
미소장 |
| 75 |
SPET imaging of central muscarinic receptors with ( R, R)[ 123I]-I-QNB: methodological considerations  |
미소장 |
| 76 |
An improved method for rapid and efficient radioiodination of iodine-123-IQNB.  |
미소장 |
| 77 |
Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease  |
미소장 |
| 78 |
In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease.  |
미소장 |
| 79 |
Brain Acetylcholinesterase Activity in Alzheimer Disease Measured by Positron Emission Tomography  |
미소장 |
| 80 |
Cognitive correlates of alterations in acetylcholinesterase in Alzheimer's disease  |
미소장 |
| 81 |
Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study.  |
미소장 |
| 82 |
Cerebral acetylcholine esterase activity in mild cognitive impairment.  |
미소장 |
| 83 |
Kinetic Analysis of Regional (S)(-)11C-Nicotine Binding in Normal and Alzheimer Brains In Vivo Assessment Using Positron Emission Tomography  |
미소장 |
| 84 |
Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex  |
미소장 |
| 85 |
Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease.  |
미소장 |
| 86 |
Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.  |
미소장 |
| 87 |
Imaging of Nicotinic and Muscarinic Receptors in Alzheimer's Disease: Effect of Tacrine Treatment  |
미소장 |
| 88 |
Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide.  |
미소장 |
| 89 |
Microglia: Intrinsic immuneffector cell of the brain  |
미소장 |
| 90 |
Phagocytosis of apoptotic inflammatory cells by microglia and its therapeutic implications: termination of CNS autoimmune inflammation and modulation by interferon-beta.  |
미소장 |
| 91 |
Microglia as mediators of inflammatory and degenerative diseases.  |
미소장 |
| 92 |
Occurrence of HLA-DR reactive microglia in Alzheimer's disease.  |
미소장 |
| 93 |
Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains.  |
미소장 |
| 94 |
Modulation of human microglial cell superoxide production by cytokines.  |
미소장 |
| 95 |
Protease production by cultured microglia: substrate gel analysis and immobilized matrix degradation.  |
미소장 |
| 96 |
Secretion of Neurotoxins by Mononuclear Phagocytes Infected with HIV-1  |
미소장 |
| 97 |
Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease.  |
미소장 |
| 98 |
High densities of benzodiazepine receptors in human cortical areas.  |
미소장 |
| 99 |
Peripheral benzodiazepine receptors and mitochondrial function  |
미소장 |
| 100 |
Isolation of the Mitochondrial Benzodiazepine Receptor: Association with the Voltage-Dependent Anion Channel and the Adenine Nucleotide Carrier  |
미소장 |
| 101 |
Shah F, Hume SP, Pike VW, Ashworth S, McDermott J. Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. Nucl Med Biol 1994; 21: 573-581. |
미소장 |
| 102 |
Yu W, Wang E, Voll RJ, Millerb AH, Goodman MM. Synthesis, fluorine-18 radiolabeling, and in vitro characterization of 1-iodophenyl-N-methyl-N-fluoroalkyl-3-isoquinoline carboxamide derivatives as potential PET radioligands for imaging peripheral benzodiazepine receptor. Bioor Med Chem 2008;16: 6145-6155. |
미소장 |
| 103 |
In-vivo measurement of activated microglia in dementia  |
미소장 |
| 104 |
PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease.  |
미소장 |
| 105 |
Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A, Eggert K, Oertel W, Banati RB, Brooks DJ. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson s disease. Neurobiol Dis 2006; 21: 404- 412. |
미소장 |
| 106 |
Ishizawa K, Dickson DW. Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration J Neuropathol Exp Neurol 2001; 60: 647- 657. |
미소장 |
| 107 |
Gerhard A, Banati RB, Goerres GB, Cagnin A, Myers R, Gunn RN, Turkheimer F, good CD, Mathias CJ, Quinn N, Schwarz J, Brooks DJ. [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology 2003; 61: 686- 689. |
미소장 |